Trial Profile
A phase II trial of gemcitabine and cisplatin in unresectable or metastatic biliary tract and gallbladder cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Biliary cancer; Gallbladder cancer
- Focus Therapeutic Use
- 01 Nov 2005 New trial record.